Results 141 to 150 of about 41,518 (220)

Surgical Outcomes Following Neoadjuvant‐Targeted Therapy for Advanced Differentiated Thyroid Cancer—Real‐World Data

open access: yesClinical Endocrinology, Volume 104, Issue 3, Page 270-280, March 2026.
ABSTRACT Background Differentiated thyroid carcinoma (DTC) is typically managed surgically with favourable outcomes. However, surgery may have dire consequences when the tumour invades critical structures. Neoadjuvant therapy with tyrosine kinase inhibitors (TKIs) has emerged as a potential strategy to improve resectability and reduce morbidity in ...
Alexandra Dorman   +15 more
wiley   +1 more source

Thyroid Hormone Replacement Dose Is Not Associated with Anti-TPO and Anti-TG Antibody Titers in Hashimoto's Disease. [PDF]

open access: yesJ Clin Med
Szczuko M   +8 more
europepmc   +1 more source

Hashimoto's thyroiditis: from pathogenesis to clinical management. [PDF]

open access: yesFront Endocrinol (Lausanne)
Wang L   +9 more
europepmc   +1 more source

Immune cell infiltration correlates with intestinal permeability, inflammation, and gastrointestinal symptoms in type 1 diabetes

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 3, Page 420-431, March 2026.
In individuals with type 1 diabetes, immune cell infiltration in the colon mucosa tended to correlate with fecal and systemic markers of intestinal permeability and inflammation, as well as gastrointestinal symptoms. These findings suggest that low‐grade gut immune activation might link the intestinal barrier dysfunction with systemic endotoxin ...
Polina Zalizko   +13 more
wiley   +1 more source

Thyroid crisis

open access: yesJournal of British Surgery, 1962
openaire   +2 more sources

Home - About - Disclaimer - Privacy